IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERGuruFocus · 14 hr ago 
E. Ohman J or Asset Management AB Makes New $731,000 Investment in Carpenter Technology Corporation $CRSDefense World · 20 hr ago 
CRS Q1 Earnings Call Highlights Aerospace Demand and Pricing GainsZacks Investment Research · 1 day ago 
Lost Money on Carpenter Technology Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 20.62% Share Price DropGuruFocus · 1 day ago 
TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026GuruFocus · 1 day ago 
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSGuruFocus · 1 day agoCarpenter Technology Corporation is a global leader in the production and supply of high-performance metallic materials, serving markets across the United States, Europe, Asia Pacific, Mexico, and Canada. The company's operations are structured into two primary divisions: Specialty Alloys Operations and Performance Engineered Products. Its diverse product portfolio encompasses advanced alloys like titanium, stainless, alloy, and tool steels, alongside various powder metals, additives, and custom-fabricated metal components.
| Date | Est. | Actual | |
|---|---|---|---|
| Oct 22, 2026 | $3.04 | $3.25 | Beat |
| Jul 30, 2026 | $3.09 | $3.23 | Beat |
| Apr 29, 2026 | $2.63 | $2.77 | Beat |
| Jan 29, 2026 | $2.22 | $2.33 | Beat |
| Oct 23, 2025 | $2.13 | $2.43 | Beat |
| Jul 31, 2025 | $2.07 | $2.21 | Beat |
